La nature passée au crible

Biofutur - Tập 1997 - Trang 10-12 - 1997
Daniel Reisdorf1
1Département des substances naturelles, RhônePoulenc Rorer, Centre de recherche de Vitry-Alfortville, 13, quai JulesGuesde, 94400 Vitry-sur-Seine, France

Tài liệu tham khảo

Betina, 1994, Bioactive secondary metabolite of microorganisms, 468 Sévenet, 1994, Plantes, molécules et médicaments, 120 Kahl, 1997, J Biomol Screening, 2, 33, 10.1177/108705719700200107 Major, 1995, J Recept Signal Transduction Res, 15, 595, 10.3109/10799899509045242 Kahl, 1996, Anal Biochem, 243, 282, 10.1006/abio.1996.0519 Kolb, 1996, J Biomol Screening, 1, 203, 10.1177/108705719600100407 Garr, 1996, J Biomol Screening, 1, 179, 10.1177/108705719600100404 Clark, 1996, Pharm Res, 13, 1133, 10.1023/A:1016091631721 Rouhi, 1997, Chem Eng News, 75, 14, 10.1021/cen-v075n014.p014 Elefteriou, 1996, Les applications thérapeutiques potentielles des toxines Kornalik, 1992, Snake toxins Dreyer, 1990, Rev Physiol Biochem Pharmacol, 115, 93, 10.1007/BFb0033953 Barbieri, 1993, Biochim et Biophys Acta, 1154, 237, 10.1016/0304-4157(93)90002-6 Kahn, 1994, Antimicrob Agents Chemother, 38, 260, 10.1128/AAC.38.2.260 Mayer, 1992, Eur J Clin Invest, 22, 113, 10.1111/j.1365-2362.1992.tb01944.x Garcia, 1993, Neuropathol Appl Neurobiol, 19, 402, 10.1111/j.1365-2990.1993.tb00461.x Silva, 1949, Am J Physiol, 156, 261, 10.1152/ajplegacy.1949.156.2.261 Ferreira, 1965, Brit J Pharmacol, 24, 163 Rothschild, 1972, tome 2 Rothschild, 1979, Snake venoms, 591 Rec INN (recommended international non proprietary name), selon la nomenclature de l'Organisation mondiale de la santé. Cushman, 1980, Enzyme inhibitors and drugs Mignat, 1995, Drug Sat, 12, 334, 10.2165/00002018-199512050-00005 Olivera, 1995, Trends Biotechnol, 13, 422, 10.1016/S0167-7799(00)88996-9 Drakopoulou, 1996, J Biol Chem, 271, 11979, 10.1074/jbc.271.20.11979 Olnes, 1990, Micro Pathol, 8, 163, 10.1016/0882-4010(90)90043-P Spitler, 1987, Cancer Res, 47, 1717 Oratz, 1990, J Biol Resp Mod, 9, 345 Byers, 1989, Cancer Res, 49, 6153 Vitetta, 1991, Cancer Res, 51, 4052 Ghetie, 1992, Blood, 80, 2315, 10.1182/blood.V80.9.2315.2315 Amlot, 1993, Blood, 82, 2624, 10.1182/blood.V82.9.2624.2624 Hodgson, 1993, Biotechnology, 11, 159, 10.1038/nbt0293-159 Gottstein, 1994, Ann Oncol, 5, 97, 10.1093/annonc/5.suppl_1.S97